|
Trabectedin 0.25 MG/1 VIAL Intravenous Powder for Solution Clinical Trials
1 actively recruiting trial across 1 location
Also known as: Yondelis
Santa Monica, California1 trial
Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Sarcoma Oncology Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.